There is No Better Way to Cure a Broken Heart® Improving outcomes for heart attack patients
Miracor Medical Systems GmbH is commercializing a new technology for improving outcomes for heart attack patients. Using an approach called cardioprotected Percutaneous Coronary Intervention (cPCITM) the method seeks to improve blood flow in the heart tissue thereby improving the overall heart function after a severe heart attack. More than 3 million patients are treated for restricted coronary blood flow every year. Of these more than 350,000 patients have poor heart tissue blood flow (microcirculation) even after successful balloon angioplasty or stent placement. Miracor is dedicated to help these patients to a better recovery after the heart attack.
cPCITM is provided by using the Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO®) technology immediately after the heart attack. The Miracor PICSO® Impulse System has received CE-mark and can be used during balloon angioplasty, stent placement or other methods for improving coronary blood flow. The cPCITM approach intermittently increases the pressure in the coronary venous system thereby redistributing blood flow into the affected heart tissue and in some patients also increases the coronary artery perfusion pressure during the procedure.
On our Web pages you will learn more about Miracor, cPCITM and future applications in interventional cardiology. Please contact us directly to receive additional information.
